According to the clinical-pathological classification, breast cancer can be divided into three groups: endocrine receptor-positive (estrogen receptor or progesterone receptor), HER2-positive (human epidermal growth factor receptor 2), and triple negative breast cancer (ER, PR, and HER2) (3). Here, ERBB2 is linked to triple-negative breast carcinoma.